9/10
09:12 am
cnsp
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock.
Low
Report
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock.
9/10
08:44 am
cnsp
Rating for CNSP
Low
Report
Rating for CNSP